Within the past few years, increasing concerns have arisen about the ways in which corporate sponsorship of clinical trials and continuing medical education activities may bias the information that is published and disseminated about the benefits and risks of medications. Questions have also been raised about the extent of industry influence on the American Psychiatric Association’s diagnostic and treatment guidelines—namely, its DSM and Clinical Practice Guidelines.
Cosgrove, Lisa and Harold J. Bursztajn, "Undue Pharmaceutical Influence on Psychiatric Practice" Psychiatric Times (May 18, 2010).
UBM Medica LLC
Bioethics and Medical Ethics Commons, Mental Disorders Commons, Pharmaceutics and Drug Design Commons, Pharmacy Administration, Policy and Regulation Commons
This article appears in the Psychiatric Times, published by UBM Medica LLC: http://www.psychiatrictimes.com/articles/undue-pharmaceutical-influence-psychiatric-practice.